Open Ankylosing Spondylitis / Axial Spondyloarthropathy in the Repurposing ExplorerAnkylosing Spondylitis / Axial Spondyloarthropathy hub
Secukinumab
Biologic · tier A · 8 trials (1 recruiting) · 16 publications · score 80.0
Adalimumab
Biologic · tier A · 8 trials (0 recruiting) · 16 publications · score 78.0
Golimumab
Biologic · tier A · 8 trials (1 recruiting) · 17 publications · score 74.5
Certolizumab Pegol
Biologic · tier A · 8 trials (0 recruiting) · 12 publications · score 73.0
Infliximab
Biologic · tier A · 8 trials (0 recruiting) · 16 publications · score 69.5
Etanercept
Biologic · tier A · 8 trials (0 recruiting) · 14 publications · score 69.0
Celecoxib
Drug · tier A · 8 trials (0 recruiting) · 7 publications · score 66.0
Naproxen
Drug · tier A · 4 trials (0 recruiting) · 9 publications · score 64.0
Indomethacin
Drug · tier A · 3 trials (0 recruiting) · 8 publications · score 52.0
Prednisolone
Drug · tier A · 3 trials (0 recruiting) · 5 publications · score 35.5
Naproxen Sodium
Drug · tier A · 4 trials (0 recruiting) · 0 publications · score 34.0
Omeprazole
Drug · tier A · 2 trials (0 recruiting) · 1 publications · score 29.0
Omeprazole Magnesium
Drug · tier A · 2 trials (0 recruiting) · 0 publications · score 27.0
Prednisone
Drug · tier A · 1 trials (0 recruiting) · 1 publications · score 27.0
Dexamethasone
Drug · tier A · 2 trials (2 recruiting) · 0 publications · score 26.0
Dexamethasone Sodium Phosphate
Drug · tier A · 2 trials (2 recruiting) · 0 publications · score 26.0
Research map, not treatment advice. Built 2026-10-07.